Skip to Content

COLSOR LOTION

Active substance(s): MENTHOL / PHENOL / TANNIC ACID

View full screen / Print PDF » Download PDF ⇩
Transcript
SUMMARY OF PRODUCT CHARACTERISTICS

1

NAME OF THE MEDICINAL PRODUCT
Colsor Lotion.

2

QUALITATIVE AND QUANTITATIVE COMPOSITION
Tannic Acid BP 5.00 % w/w,
Phenol BP 0.50 % w/w,
Menthol BP 0.50 % w/w

3

PHARMACEUTICAL FORM
Topical Solution

4

CLINICAL PARTICULARS

4.1

Therapeutic indications
For the relief of symptoms of Cold Sores and Sun-Blistered lips.

4.2

Posology and method of administration
Apply Colsor lotion sparingly two or three times daily.

4.3

Contraindications
None stated.

4.4

Special warnings and precautions for use
Avoid contact with eyes.
Keep all medicine out of reach of children.

4.5

Interaction with other medicinal products and other forms of interaction
None Stated.

4.6

Fertility, Pregnancy and lactation
None Stated.

4.7

Effects on ability to drive and use machines
None Stated.

4.8

Undesirable effects
None Stated.

4.9

Overdose
Not applicable,

5

PHARMACOLOGICAL PROPERTIES

5.1

Pharmacodynamic properties
Tannic Acid BP:
Menthol BP:
Phenol BP:

Used in this product for it s astringent properties.
Relieves itching. It also causes a sensation of coldness,
followed by an analgesic effect.
Is a disinfectant, effective against gram-positive and
gram-negative bacteria. It is also effective against certain
viruses.

5.2

Pharmacokinetic properties
Not Applicable.

5.3

Preclinical safety data
Not Applicable.

6

PHARMACEUTICAL PARTICULARS

6.1

List of excipients
IMS BP.

6.2

Incompatibilities
None Stated.

6.3

Shelf life
36 Months.

6.4

Special precautions for storage
Dry frost free below 25 C.

6.5

Nature and contents of container
Amber glass vial containing 10ml.

6.6

Special precautions for disposal
Apply Colsor Lotion sparingly two or three times daily. Avoid contact with
the eyes.

7

MARKETING AUTHORISATION HOLDER
Optima Consumer Health Ltd
Concept house,
Brackenbeck Road,
Bradford,
BD7 2LW,
UK

8

MARKETING AUTHORISATION NUMBER(S)
PL 40575/0003

9

DATE OF FIRST AUTHORISATION/RENEWAL OF THE
AUTHORISATION
3 December 1997

10

DATE OF REVISION OF THE TEXT
31/07/2012

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide